Pre-existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma.,Journal of Diabetes

当前位置： X-MOL 学术 › J. Diabetes › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Pre-existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma.
Journal of Diabetes ( IF 4.5 ) Pub Date : 2019-06-26 , DOI: 10.1111/1753-0407.12957
Haosen Yang ₁ , Keqiang Yin ₁ , Yusheng Wang ₁ , Mancheng Xia ₁ , Ruiqin Zhang ₁ , Wenzhan Wang ₂ , Jiawei Chen ₁ , Chaoqi Wang ₁ , Weibing Shuang ₁

Affiliation

Diabetes is a risk factor for various cancers, but its prognostic role in renal cell carcinoma (RCC) is controversial and understudied. This study investigated the prognostic value of type 2 diabetes (T2D) in RCC patients.

中文翻译：